AR Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,862
Closed -$583K 124
2026
Q1
$583K Buy
+15,862
New +$752K 0.11% 96
2025
Q3
Sell
-28,240
Closed -$1.95M 114
2025
Q2
$1.95M Buy
28,240
+17,740
+169% +$1.21M 0.43% 53
2025
Q1
$729K Buy
+10,500
New +$867K 0.17% 83

Other funds holding NVO

AR Asset Management's NVO Position: Q2 2026 in Review

AR Asset Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 15,862 shares — an estimated $583K sold.

AR Asset Management first reported a position in NVO in Q1 2025 and held it in 3 quarters. The position peaked at $1.95M in Q2 2025. 1,191 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • AR Asset Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • AR Asset Management sold 15,862 Novo Nordisk shares in Q2 2026, an estimated $583K.
  • AR Asset Management first reported a position in Novo Nordisk in Q1 2025 and held it in 3 quarters.
  • AR Asset Management's Novo Nordisk position peaked at $1.95M in Q2 2025.
  • 1,191 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on AR Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.